# Iron Isomaltoside for the Treatment of Anemia in Peritoneal Dialysis Patients

> **NCT06830941** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Xie Jingyuan, MD** · enrollment: 124 (estimated)

## Conditions studied

- Renal Anemia
- Peritoneal Dialysis (PD)

## Interventions

- **DRUG:** Iron isomaltoside
- **DRUG:** Ferrous succinate

## Key facts

- **NCT ID:** NCT06830941
- **Lead sponsor:** Xie Jingyuan, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-02-15
- **Primary completion:** 2027-02-09
- **Final completion:** 2027-12-31
- **Target enrollment:** 124 (ESTIMATED)
- **Last updated:** 2025-02-17

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06830941

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06830941, "Iron Isomaltoside for the Treatment of Anemia in Peritoneal Dialysis Patients". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06830941. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*